NRX PharmaceuticalsNRXP
13F holders, Q3 2025 (September 30)24holders −1
4new positions
5sold out
1famous investor
$3.30avg. 13F price*
At the end of Q3 2025, 24 institutions reported holding NRX Pharmaceuticals Inc. (NRXP) in their 13F filings, down 1 from Q2 2025. 4 opened new positions and 5 sold out. The largest holders were Anson Funds Management LP ($6.7M), Vanguard Group Inc. ($1.8M) and AdvisorShares Investments LLC ($1.1M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- NRX Pharmaceuticals Inc.
- CUSIP
- 629444209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $830K |
| Exits | 5 | $459K |
All 13F filers, Q2 2025 → Q3 2025: 1,105,042 shares bought and 142,780 shares sold, net +962,262 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 24 holders
| Anson Funds Management LP | 0.77% | Add +26.2% | 2,025,104 | $6.7M |
| Vanguard Group Inc. | 0.00% | Add +18.3% | 534,956 | $1.8M |
| AdvisorShares Investments LLC | 0.18% | Add +29.7% | 342,136 | $1.1M |
| Marshall Wace, LLP | 0.00% | Add +466.6% | 189,136 | $624K |
| Geode Capital Management, LLC | 0.00% | Add +7.9% | 185,862 | $613K |
| UBS Group AG | 0.00% | Add +25.7% | 152,848 | $504K |
| Renaissance Technologies | 0.00% | New | 128,175 | $423K |
| State Street Corp. | 0.00% | Add +49.3% | 76,284 | $252K |
| Jane Street Group, LLC | 0.00% | New | 73,399 | $242K |
| BlackRock, Inc. | 0.00% | Add +1.6% | 65,412 | $216K |
| Two Sigma Investments, LP | 0.00% | Add +66.4% | 52,332 | $173K |
| Chicago Partners Investment Group LLC | 0.00% | New | 41,994 | $126K |
| Northern Trust Corp. | 0.00% | No change | 28,601 | $94K |
| One Wealth Management Investment & Advisory Services, LLC | 0.11% | Add +86.1% | 27,991 | $92K |
| Ethos Financial Group, LLC | 0.00% | New | 11,900 | $39K |
| Morgan Stanley | 0.00% | Add +152.1% | 11,080 | $37K |
| Bank of America Corp. | 0.00% | Reduce -3.5% | 3,400 | $11K |
| SBI Securities Co., Ltd. | 0.00% | Reduce -26.3% | 2,500 | $8K |
| Wells Fargo & Company | 0.00% | No change | 2,000 | $7K |
| Osaic Holdings, Inc. | 0.00% | Add +1111.1% | 1,090 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -72.0% | 324 | $1K |
| Carolina Wealth Advisors, LLC | 0.00% | No change | 50 | $165 |
| JPMorgan Chase & Co. | 0.00% | No change | 34 | $112 |
| Larson Financial Group LLC | 0.00% | No change | 22 | $73 |
"% of holder's portfolio" is NRXP's weight in each manager's 13F, not the share of NRX Pharmaceuticals Inc. the manager owns.